Skip to content

Instinct™ Ultrasound Device Safety, Efficacy and Usability

Mobile, Self-Operated, Home Ultrasound in Pregnancy - Safety, Efficacy and Usability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04399408
Enrollment
100
Registered
2020-05-22
Start date
2019-05-06
Completion date
2020-07-25
Last updated
2023-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ultrasonography, Prenatal

Brief summary

Mobile medical devices for self-patient-use, are a rapidly evolving component of telehealth. Study examines the feasibility of using the INSTINCT® device, a portable self-use ultrasound system attached to a commercial smartphone in remote pregnancy assessment. Study aims to evaluate its safety, efficacy and usability.

Detailed description

Study includes women carrying a singleton fetus at 14 to 40 gestational weeks. Women with multiple gestations, non-viable fetus at recruitment and those with a major fetal anatomical malformation or genetic syndrome are excluded. Each participant receives the device for a self-use period of 7-14 days, instructed to preform 1-3 scans a day. Each participant completes a self-assessment questionnaire which aims to evaluate satisfactory and usability (user experience and satisfaction). Each scan will be evaluated for the possibility to properly view fetal heart activity, amniotic fluid volume, fetal tone, fetal body and breathing movements.

Interventions

DEVICEObstetrics Ultrasound (non invasive)

Participants are instructed to preform 1-3 short (3 minuets) ultrasound scans a day according to pre-defined steps.

Sponsors

PulseNmore
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18. * Pregnancy week - 14-40. * Fetus - single, no known genetic or anatomic defects. * Able to understand and give informed consent.

Exclusion criteria

* Multiple pregnancy. * Known genetic or anatomic defect to the fetus. * Inability to understand how to operate the device or give informed

Design outcomes

Primary

MeasureTime frameDescription
Safety - Device related SAE'sThrough study completion until all subject gave birth, an average of 1 yearThe device will be deemed safe if all SAE will be classified as not device related

Secondary

MeasureTime frameDescription
User experience levelThrough study completion, an average of 1 yearUser experience will be defined positive if the mean value of all answers to user satisfaction related questions in the CRF is better or equal 3.5 out of 5. Questions will be graded by a visual analog scale with scores of 1 to 5 (1=very poor, 5=very high)
Usability ratingThrough study completion, an average of 1 yearUsability will be defined positive if the mean value of all answers to usability related questions in the CRF is better or equal 3.5 out of 5. Questions will be graded by a visual analog scale with scores of 1 to 5 (1=very poor, 5=very high)
Device Sensitivity levelThrough study completion, an average of 1 yearMedical data recorded by the device will be defined useful if: At least 70% of 3 out of 5 tested parameters (Fetal Heartbeat, Movements, Tone, Breathing and Amniotic fluids) were classified by professional evaluator as could be estimated. In more than 90% of scans, professional evaluator will be able to define Fetal Viability (identification of at least one of the following parameters: Fetal Heartbeat, Movements, Tone and Breathing)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026